▲ Peaking
Business
🔮 fades
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
Deerfield-backed startup Boulevard Bio launches with a $65 million seed to pursue a trio of targeted immunology drugs.